Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for CorMedix (CRMD) over the last 11 years, with Q3 2025 value amounting to $276.0.

  • CorMedix's Exchange Rate Effect fell 3349.4% to $276.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $102.0, marking a year-over-year decrease of 9435.22%. This contributed to the annual value of -$1709.0 for FY2024, which is 16086.18% down from last year.
  • According to the latest figures from Q3 2025, CorMedix's Exchange Rate Effect is $276.0, which was down 3349.4% from $828.0 recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Exchange Rate Effect peaked at $15787.0 during Q4 2022, and registered a low of -$10909.0 during Q3 2022.
  • Its 5-year average for Exchange Rate Effect is -$1230.5, with a median of -$446.5 in 2024.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 43875.29% in 2022, then soared by 104090.91% in 2025.
  • Over the past 5 years, CorMedix's Exchange Rate Effect (Quarter) stood at -$3120.0 in 2021, then soared by 605.99% to $15787.0 in 2022, then plummeted by 85.53% to $2284.0 in 2023, then crashed by 153.9% to -$1231.0 in 2024, then skyrocketed by 122.42% to $276.0 in 2025.
  • Its Exchange Rate Effect stands at $276.0 for Q3 2025, versus $828.0 for Q2 2025 and $229.0 for Q1 2025.